EBNM

AcronymDefinition
EBNMEuropean Board of Nuclear Medicine (European Association of Nuclear Medicine, Vienna, Austria)
References in periodicals archive ?
The latency to the first entry to the target quadrant (Figure2(c)) of each group was determined as follows: estrogen (4.90 [+ or -] 1.33) < control (4.97 [+ or -] 1.93) < EBNL (4.38 [+ or -] 1.22) < sham (5.33 [+ or -] 1.40) < EBNH (6.02 [+ or -] 2.33) < EBNM (6.42 [+ or -] 2.59) < OVX (10.62 [+ or -] 2.87).
A: sham group (A1, first day first trial; A2, probe trial); B: OVX group (B1, first day first trial; B2, probe trial); C: estrogen group (C1, first day first trial; C2, probe trial); D: EBNH group (D1, first day first trial; D2, probe trial); E: EBNM group (E1, first day first trial; E2, probe trial); F: EBNL group (F1, first day first trial; F2, probe trial).